SCHEMBL2371337

SCHEMBL2371337

Cc1nc(N)c(C)c(N)n1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.39
HSP90AB1 P08238 1/20 0.36
PDE10A Q9Y233 1/20 0.34
ADORA1 P30542 4/20 0.32
ADORA2A P29274 3/20 0.32
ADORA3 P0DMS8 1/20 0.32
HTT P42858 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HSP90AA1 P07900 1/20 0.32
NOS3 P29474 1/20 0.32
NOS2 P35228 1/20 0.32
ADORA2B P29275 1/20 0.31
NPY5R Q15761 1/20 0.31
ALDH1A1 P00352 2/20 0.31
IDO1 P14902 1/20 0.31
LIMK1 P53667 1/20 0.31
KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1830380 0.84 LMNA (0.40) LMNAHSP90AB1PDE10AHTTSMN1; SMN2
SCHEMBL4330004 0.80 HSP90AB1 (0.33) LMNAHSP90AB1ADORA1ADORA2AADORA3
SCHEMBL259072 0.80 PDE10A (0.52) LMNAHSP90AB1PDE10AADORA1ADORA2A
SCHEMBL16938750 0.80 LMNA (0.32) LMNAHSP90AB1SMN1; SMN2ALDH1A1
SCHEMBL6424033 0.79 HSP90AB1 (0.36) LMNAHSP90AB1ADORA1ADORA2AADORA3
SCHEMBL10049719 0.79 LMNA (0.39) LMNAHSP90AB1PDE10AADORA2AALDH1A1
SCHEMBL16094459 0.76 ADORA1 (0.39) LMNAHSP90AB1ADORA1ADORA2AADORA3
SCHEMBL7522506 0.76 LMNA (0.38) LMNAPDE10ANOS3NOS2ALDH1A1
SCHEMBL2371941 0.76 MAP2K7 (0.30) LMNAHTTSMN1; SMN2
SCHEMBL5561175 0.76 ALDH1A1 (0.31) HSP90AB1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111587112-B Rho-related inhibitors of coiled-coil-containing protein kinases 卡德门企业有限公司 2023-10-10 CN disclosed
US-20230174519-A1 Inhibitors of Rho Associated Coiled-Coil Containing Protein Kinase KADMON CORPORATION, LLC (US) 2023-06-08 US disclosed
US-11613531-B2 Inhibitors of RHO associated coiled-coil containing protein kinase KADMON CORPORATION, LLC (US) 2023-03-28 US disclosed
US-20200199109-A1 Inhibitors of RHO Associated Coiled-Coil Containing Protein Kinase KADMON CORPORATION, LLC 2020-06-25 US disclosed
US-20130096104-A1 IMIDAZOPYRIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE GENENTECH, INC. (US) 2013-04-18 US disclosed
WO-2011113802-A2 IMIDAZOPYRIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE F. HOFFMANN-LA ROCHE AG (CH) 2011-09-22 WO disclosed
US-20070197523-A1 CALCIUM CHANNEL ANTAGONISTS ICAGEN, INC. (US) 2007-08-23 US disclosed
WO-2004034967-A2 2,4,6-TRIAMINOPYRIMIDINES FOR THE TREATMENT OF DEPRESSION AND/OR ANXIETY SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2004-04-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130096104-A1 IMIDAZOPYRIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE TYK2, IRAK1, IRAK4 LMNA 2401/4885HSP90AB1 2317/4885PDE10A 4101/4885
US-20230174519-A1 Inhibitors of Rho Associated Coiled-Coil Containing Protein Kinase ROCK1, ROCK2, RHOT2 LMNA 2071/4885HSP90AB1 327/4885PDE10A 1234/4885
US-20200199109-A1 Inhibitors of RHO Associated Coiled-Coil Containing Protein Kinase ROCK1, ROCK2, RHOT2 LMNA 2071/4885HSP90AB1 327/4885PDE10A 1234/4885
US-11613531-B2 Inhibitors of RHO associated coiled-coil containing protein kinase ROCK1, ROCK2, RHOT2 LMNA 2071/4885HSP90AB1 327/4885PDE10A 1234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.